Effects of Lycopene on the Expression of Cytochrome P_(450)2E1 and Tumor Necrosis Factor-α in Liver Tissues of Rats with Nonalcoholic Fatty Liver
Zhao Chun-jing
Abstract
Zhao Chun-jing
Abstract
OBJECTIVE: To explore the effects of lycopene on the expression of cytochrome P450 2E1 and tumor necrosis factor-α in liver tissues of rats with nonalcoholic fatty liver. METHODS: Rats were divided into normal control (N) group and modeling group. Modeling group was given high-fat diet for 8 weeks to establish fatty liver model. Then model rats were divided into model control (M) group (high-fat diet), lycopene low-dose (L) group (normal diet, lycopene 10 mg·kg-1), lycopene high-dose (H) group (normal diet, lycopene 20 mg·kg-1) and natural recovery (NR) group (normal diet) with 10 rats of each group. Those groups were given diet for 4 weeks then sacrificed. The change of histopathology was observed. The levels of CYP2E1, TNF-α, SOD, MDA and FFA in liver tissue were detected. RESULTS: Compared with M group, the changes of histopathology in NR group, L group and H group were improved, especially in L group and H group. Compared with NR group, the levels of CYP2E1, TNF-α, MDA and FFA in liver tissue of L group and H group were decreased significantly (P0.05); the level of SOD was increased significantly (P0.05 or P0.01). CONCLUSION: Lycopene can significantly inhibit the expression of CYP2El and TNF-α in fatty liver rats and reduce lipid peroxidation so as to improve fatty liver.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To explore the effects of lycopene on the expression of cytochrome P450 2E1 and tumor necrosis factor-α in liver tissues of rats with nonalcoholic fatty liver. METHODS: Rats were divided into normal control (N) group and modeling group. Modeling group was given high-fat diet for 8 weeks to establish fatty liver model. Then model rats were divided into model control (M) group (high-fat diet), lycopene low-dose (L) group (normal diet, lycopene 10 mg·kg-1), lycopene high-dose (H) group (normal diet, lycopene 20 mg·kg-1) and natural recovery (NR) group (normal diet) with 10 rats of each group. Those groups were given diet for 4 weeks then sacrificed. The change of histopathology was observed. The levels of CYP2E1, TNF-α, SOD, MDA and FFA in liver tissue were detected. RESULTS: Compared with M group, the changes of histopathology in NR group, L group and H group were improved, especially in L group and H group. Compared with NR group, the levels of CYP2E1, TNF-α, MDA and FFA in liver tissue of L group and H group were decreased significantly (P0.05); the level of SOD was increased significantly (P0.05 or P0.01). CONCLUSION: Lycopene can significantly inhibit the expression of CYP2El and TNF-α in fatty liver rats and reduce lipid peroxidation so as to improve fatty liver.
Key concepts: Lycopene, CYP2E1, Internal medicine, Endocrinology, Fatty liver, Histopathology, Tumor necrosis factor alpha, Nonalcoholic fatty liver disease